Is your clinical diagnostics contract manufacturer prepared to weather supply chain challenges?

Supply chain security and transparency is a key part of the risk mitigation strategy of companies manufacturing clinical diagnostic assays. Covid-19-driven regional manufacturing shutdowns, surge demands, and logistics disruptions have placed significant pressure on clinical diagnostic supply chains, resulting in raw material shortages and delays. In this application note, explore some of the key factors to consider when choosing a contract manufacturing organization (CMO) partner to relieve manufacturing constraints and increase capacity during turbulent times.